Not applicableUnknownNCT05527808What this trial is testingA Single-arm Exploratory Study of Neoadjuvant TherapyWho this might be right forLung Adenocarcinoma Jun Liu 28
Early research (Phase 1)Looking for participantsNCT07630961What this trial is testingPhase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid TumorsWho this might be right forMetastatic Pancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)HR+/HER2- Ductal Breast Cancer (BC)+4 more Novartis Pharmaceuticals 66
Early research (Phase 1)Study completedNCT00102505What this trial is testingMotexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small-Cell Lung CarcinomaCarcinoma, Bronchogenic Pharmacyclics LLC. 36
Not applicableLooking for participantsNCT04937283What this trial is testingSegmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cmWho this might be right forLung Adenocarcinoma Shanghai Pulmonary Hospital, Shanghai, China 690
Not applicableStudy completedNCT04795245What this trial is testingNon-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung AdenocarcinomaWho this might be right forNon-squamous, Non-Small Cell Lung Cancer Boehringer Ingelheim 805
Early research (Phase 1)Ended earlyNCT02012231What this trial is testingPhase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.Who this might be right forMelanomaThyroid CancerColorectal Cancer+4 more Fore Biotherapeutics 5
Testing effectiveness (Phase 2)Looking for participantsNCT07174583What this trial is testingIDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung CancerWho this might be right forSmall-cell Lung CancerNeuroendocrine CarcinomasSolid Tumor Show to Express DLL3 IDEAYA Biosciences 262
Testing effectiveness (Phase 2)UnknownNCT00339586What this trial is testingFirst-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR GeneWho this might be right forLung NeoplasmsNon-Small Cell Lung CancerAdenocarcinoma, Bronchiolo-Alveolar Universitair Ziekenhuis Brussel 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272What this trial is testingA Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid MalignanciesWho this might be right forSolid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more 23andMe, Inc. 141
Early research (Phase 1)Study completedNCT04344795What this trial is testingPhase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid TumorsWho this might be right forSolid TumorColorectal CancerNon Small Cell Lung Cancer+6 more Tempest Therapeutics 89
Testing effectiveness (Phase 2)Ended earlyNCT02839681What this trial is testingAnti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung AdenocarcinomaWho this might be right forLung Neoplasms National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Study completedNCT03679767What this trial is testingINCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)Who this might be right forMetastatic Non-small Cell Lung CancerLocally Advanced Urothelial CancerMetastatic Urothelial Cancer+4 more Incyte Corporation 121
Testing effectiveness (Phase 2)Active Not RecruitingNCT03228667What this trial is testingQUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsWho this might be right forNon-Small Cell Lung CancerSmall Cell Lung CancerUrothelial Carcinoma+10 more ImmunityBio, Inc. 40
Not applicableActive Not RecruitingNCT04314401What this trial is testingNational Cancer Institute "Cancer Moonshot Biobank"Who this might be right forAcute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more National Cancer Institute (NCI) 1,600
Testing effectiveness (Phase 2)Study completedNCT00923481What this trial is testingA Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...Who this might be right forHead and Neck NeoplasmsPheochromocytomaColorectal Neoplasms+2 more National Cancer Institute (NCI) 37
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Looking for participantsNCT06923761What this trial is testingEMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)Who this might be right forAdvanced Solid Malignancy Grey Wolf Therapeutics 300
Early research (Phase 1)Study completedNCT01579994What this trial is testingCrizotinib and Ganetespib (STA-9090) in ALK Positive Lung CancersWho this might be right forAdvanced Lung Cancer Memorial Sloan Kettering Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Not applicableLooking for participantsNCT07192991What this trial is testingNeuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin AmericaWho this might be right forNeuroendocrine CarcinomasLung Neuroendocrine Carcinoma Latin American Cooperative Oncology Group 200